Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population


Mutations in KRAS and BRAF genes were associated with treatment failure from EGF receptor inhibitors in colorectal cancer (CRC) patients. However, whether these mutations were associated with survival in patients not treated with EGF receptor inhibitors remained controversial. Moreover, few data were available in Chinese. Therefore, we aimed to evaluate the… (More)
DOI: 10.1007/s00384-011-1229-1


6 Figures and Tables